Subcellular localization of Nox4 and regulation in diabetes
- PMID: 19706525
- PMCID: PMC2732863
- DOI: 10.1073/pnas.0906805106
Subcellular localization of Nox4 and regulation in diabetes
Abstract
Oxidative stress is implicated in human diseases. Some of the oxidative pathways are harbored in the mitochondria. NAD(P)H oxidases have been identified not only in phagocytic but also in somatic cells. Nox4 is the most ubiquitous of these oxidases and is a major source of reactive oxygen species (ROS) in many cell types and in kidney tissue of diabetic animals. We generated specific Nox4 antibodies, and found that Nox4 localizes to mitochondria. (i) Immunoblot analysis in cultured mesangial cells and kidney cortex revealed that Nox4 is present in crude mitochondria, in mitochondria-enriched heavy fractions, and in purified mitochondria; (ii) immunofluorescence confocal microscopy also revealed that Nox4 localizes with the mitochondrial marker Mitotracker; and (iii) the mitochondrial localization prediction program MitoProt indicated that the probability score for Nox4 is identical to mitochondrial protein cytochrome c oxidase subunit IV. We also show that in purified mitochondria, siRNA-mediated knockdown of Nox4 significantly reduces NADPH oxidase activity in pure mitochondria and blocks glucose-induced mitochondrial superoxide generation. In a rat model of diabetes, mitochondrial Nox4 expression is increased in kidney cortex. Our data provide evidence that a functional Nox4 is present and regulated in mitochondria, indicating the existence of a previously undescribed source of ROS in this organelle.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2732863/bin/zpq9990992710001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2732863/bin/zpq9990992710002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2732863/bin/zpq9990992710003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2732863/bin/zpq9990992710004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2732863/bin/zpq9990992710005.gif)
![Fig. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2732863/bin/zpq9990992710006.gif)
Similar articles
-
Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells.J Biol Chem. 2013 Mar 8;288(10):6835-48. doi: 10.1074/jbc.M112.419101. Epub 2013 Jan 17. J Biol Chem. 2013. PMID: 23329835 Free PMC article.
-
Mitochondrial-localized NADPH oxidase 4 is a source of superoxide in angiotensin II-stimulated neurons.Am J Physiol Heart Circ Physiol. 2013 Jul 1;305(1):H19-28. doi: 10.1152/ajpheart.00974.2012. Epub 2013 Apr 26. Am J Physiol Heart Circ Physiol. 2013. PMID: 23624625 Free PMC article.
-
Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes.Am J Physiol Cell Physiol. 2012 Feb 1;302(3):C597-604. doi: 10.1152/ajpcell.00331.2011. Epub 2011 Oct 26. Am J Physiol Cell Physiol. 2012. PMID: 22031600 Free PMC article.
-
Nox4 as a novel therapeutic target for diabetic vascular complications.Redox Biol. 2023 Aug;64:102781. doi: 10.1016/j.redox.2023.102781. Epub 2023 Jun 9. Redox Biol. 2023. PMID: 37321060 Free PMC article. Review.
-
Bone disorders: targeting NOX4 knocks down osteoporosis.Nat Rev Drug Discov. 2013 Dec;12(12):904. doi: 10.1038/nrd4182. Nat Rev Drug Discov. 2013. PMID: 24287775 Review. No abstract available.
Cited by
-
Endothelial NOX5 Obliterates the Reno-Protective Effect of Nox4 Deletion by Promoting Renal Fibrosis via Activation of EMT and ROS-Sensitive Pathways in Diabetes.Antioxidants (Basel). 2024 Mar 26;13(4):396. doi: 10.3390/antiox13040396. Antioxidants (Basel). 2024. PMID: 38671844 Free PMC article.
-
Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression.Int J Mol Sci. 2024 Jan 25;25(3):1504. doi: 10.3390/ijms25031504. Int J Mol Sci. 2024. PMID: 38338783 Free PMC article. Review.
-
Mitochondrial Dynamics in Pulmonary Hypertension.Biomedicines. 2023 Dec 25;12(1):53. doi: 10.3390/biomedicines12010053. Biomedicines. 2023. PMID: 38255160 Free PMC article. Review.
-
NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases.Neural Regen Res. 2024 Sep 1;19(9):1961-1966. doi: 10.4103/1673-5374.390973. Epub 2023 Dec 15. Neural Regen Res. 2024. PMID: 38227522 Free PMC article.
-
Activation of the Nrf-2/HO-1 signalling axis can alleviate metabolic syndrome in cardiovascular disease.Ann Med. 2023;55(2):2284890. doi: 10.1080/07853890.2023.2284890. Epub 2023 Dec 1. Ann Med. 2023. PMID: 38039549 Free PMC article. Review.
References
-
- Schnackenberg CG. Oxygen radicals in cardiovascular-renal disease. Curr Opin Pharmacol. 2002;2:121–125. - PubMed
-
- Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 2005;54:1615–1625. - PubMed
-
- Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95. - PubMed
-
- Duchen MR. Roles of mitochondria in health and disease. Diabetes. 2004;53:S96–S102. - PubMed
-
- Nishikawa T, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787–790. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous